An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive Method

CompletedOBSERVATIONAL
Enrollment

1,039

Participants

Timeline

Start Date

September 18, 2015

Primary Completion Date

July 1, 2016

Study Completion Date

September 28, 2016

Conditions
Quality of Life
Interventions
DRUG

Levonorgestrel (Jaydess, BAY86-5028)

Intrauterine delivery system Jaydess (13.5 mg levonorgestrel)

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY